Literature DB >> 11846458

Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.

J Bartůnková1, I Kolárová, A Sedivá, E Hölzelová.   

Abstract

Differential diagnosis between ulcerative colitis (UC) and Crohn's disease (CD) is difficult in the initial phases in pediatric patients with inflammatory bowel diseases (IBD). This study was performed to determine the significance of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in IBD. ANCA were specified with regard to their antigenic specifity, significance to the diagnosis, and correlation of titer with the disease activity. The occurrence of food allergy was questioned, too. Serum samples from 44 children with UC (n = 23) or CD (n = 21) and from disease-control children (coeliac disease, n = 21) were analyzed for IgG ANCA, ANCA target antigens, IgA and IgG ASCA, and IgE to food allergens. Results show that ANCA occur more frequently in UC than in CD and disease-control (74, 24, and 10%, respectively). The presence of ANCA does not reflect disease activity. Antigenic specificity does not differ in any group. IgA-ASCA are found more often in patients with CD (76% versus 17% in UC). The testing for both ANCA and ASCA enabled clear-cut differential diagnosis between UC and CD based on the high specificity (ANCA+ ASCA- 92.5% for UC, ANCA- ASCA+ 93.2% for CD). Specific IgE to food allergens were found in 8.7, 14.3, and 23.8% of patients with UC, CD, and coeliac disease, respectively. We conclude that combined testing of ANCA and ASCA represents a valuable tool in the differential diagnosis between UC and CD in pediatric patients, minimizing invasive diagnostic procedures. Monitoring of ANCA, its specificity, and titer determination does not bring more information. Testing for specific IgE to food allergens may be considered in individual patients. Copyright 2001 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846458     DOI: 10.1006/clim.2001.5145

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

1.  Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.

Authors:  M S Buckland; M Mylonaki; D Rampton; H J Longhurst
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

Authors:  James Markowitz; Subra Kugathasan; Marla Dubinsky; Ling Mei; Wallace Crandall; Neal LeLeiko; Maria Oliva-Hemker; Joel Rosh; Jonathan Evans; David Mack; Anthony Otley; Marian Pfefferkorn; Ron Bahar; Eric Vasiliauskas; Ghassan Wahbeh; Gary Silber; J Antonio Quiros; Iwona Wrobel; Justin Nebel; Carol Landers; Yoanna Picornell; Stephan Targan; Trudy Lerer; Jeffrey Hyams
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 3.  Management of inflammatory bowel diseases in Eastern Europe.

Authors:  L Lakatos; P L Lakatos
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

4.  Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.

Authors:  Kleanthis G Dendrinos; James M Becker; Arthur F Stucchi; Lawrence J Saubermann; Wayne LaMorte; Francis A Farraye
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

5.  Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease.

Authors:  N W Savage; K Barnard; P J Shirlaw; D Rahman; M Mistry; M P Escudier; J D Sanderson; S J Challacombe
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

6.  Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.

Authors:  Sara Ashorn; Teemu Honkanen; Kaija-Leena Kolho; Merja Ashorn; Tuuli Välineva; Bo Wei; Jonathan Braun; Immo Rantala; Tiina Luukkaala; Sari Iltanen
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

7.  Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.

Authors:  Florian Rieder; Rocio Lopez; Andre Franke; Alexandra Wolf; Stephan Schleder; Andrea Dirmeier; Anja Schirbel; Philip Rosenstiel; Nir Dotan; Stefan Schreiber; Gerhard Rogler; Frank Klebl
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

8.  Induction of colitis in mice with food allergen-specific immune response.

Authors:  Lin-Jing Li; Lu Zeng; Xiao-Xi Li; Li-Hua Mo; Xiao-Rui Geng; Peng-Yuan Zheng; Zhi-Gang Liu; Bai-Sui Feng; Ping-Chang Yang
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

9.  Eosinophilic colitis in children.

Authors:  Urszula Grzybowska-Chlebowczyk; Sabina Horowska-Ziaja; Maciej Kajor; Sabina Więcek; Wojciech Chlebowczyk; Halina Woś
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

10.  Serologic investigations in children with inflammatory bowel disease and food allergy.

Authors:  Urszula Grzybowska-Chlebowczyk; Halina Woś; Aleksander L Sieroń; Sabina Wiecek; Aleksandra Auguściak-Duma; Halina Koryciak-Komarska; Joanna Kasznia-Kocot
Journal:  Mediators Inflamm       Date:  2009-12-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.